A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual ...

The innovative treatment, provided by Abu Dhabi Stem Cells Center (ADSCC), in coordination with DoH and in collaboration with ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

Sebastien Beauzile became the first person in NY to be made symptom-free after undergoing a new type of gene therapy.

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy ... based therapy will be an option for SCD patients aged 12 years and over who have ...

“Sickle cell is a debilitating, often-overlooked disease ... Casgevy (Vertex pharmaceuticals) were both FDA-approved in late 2023 for the treatment of sickle cell anemia in patients 12 and ...